“We seek to do more than incrementally improve diagnostics and treatment,
but rather to invent complete and novel solutions to unmet clinical needs.”

With several decades of combined expertise in spearheading diagnostic solutions, our team of medical, technology and healthcare experts is singly focused on developing innovative, patented technologies for cardiology, respiratory and other complex disease states that are uniquely designed to enhance clinical efficacy to the benefit of patients and physicians. Our medical devices and systems are created to be physician- and patient-centric, utilizing the most advanced algorithms and software that provide improvements in mean time to diagnosis and treatment.

Min Kim, CEO

Mr. Kim currently serves in dual executive leadership roles, most recently as CEO of Cardiac Insight, as well as of Dreamtech, a Korean EMS (Electronics Manufacturing Service) provider of smartphones and medical devices, including cardiac diagnostic and monitoring solutions.
Since joining Dreamtech in 2014, Mr. Kim has successfully executed a number of international strategic alliances and M&As to reinforce the company’s competitiveness in the field of medical device development & manufacturing and brought the company public in early 2019 with a market cap of $600 million. Prior to Dreamtech, Mr. Kim served at various investment banking firms including at Samsung Securities and Lehman Brothers, where he was instrumental in closing M&A and fundraising transactions totaling more than $5 billion. Mr. Kim holds an MBA from the Wharton School of the University of Pennsylvania and a BS in Finance from the University of Southern California.

Roy Kim, CFO
Roy Kim

Prior to joining Cardiac Insight, Mr. Kim served as Senior Vice President & Area Banking Manager at Hanmi Bank, a specialty community-focused bank with corporate headquarters in Los Angeles, California. He was responsible for managing commercial clients with over $500 million in assets, and liabilities of over $1.2 billion.  He was also accountable for overall team leadership and financial management, including oversight of credit portfolios and client deposit relationships. Mr. Kim has served at various commercial banks in Southern California as credit manager, portfolio manager, and asset and liability manager. He holds a BS in Finance from the University of Southern California and a Certificate of Global CEO program from Yeonsei University.

Dan Tylutki, COO
Dan Tylutki

A 20-year veteran in medical device development, Mr. Tylutki has driven product development management, project management, medical device quality systems and regulatory affairs for a variety of industry leaders, including Varian Medical Systems, Wavtrace, Mindplay, Northstar Neuroscience, Light Sciences Oncology, where he was particularly effective leading engineer teams through the entire product development lifecycle. With a master’s in electrical engineering, Mr. Tylutki brings his FDA class II/III medical device development to Cardiac Insight, where he is motivated to fulfill a personal mission to enhance quality of life for patients and their families.

Dave Hadley, PhD, CTO
Dave Hadley

Dr. Hadley has over 30 years of hands-on experience blending customer needs with information technology through research and development. He spent nine years as Vice President of Research and Development for Quinton Cardiology. In this role, Dr. Hadley was responsible for rebuilding the engineering team, establishing robust new product architectures and developing the next generation of Quinton and Burdick diagnostic ECG products. Prior to his role at Quinton Cardiology, Dr. Hadley was with Primus Knowledge Solutions and Sierra Geophysics. He earned his PhD from the California Institute of Technology.

Ann Demaree, Senior VP of Marketing & Business Development
Ann Demaree

Ann Demaree is former VP of Business Development and Alliances for Welch Allyn Monitoring and VP of Marketing & BD for CapsuleTech, with prior management positions at Biotronik, CR Bard and Becton Dickinson. She brings over 25 years of medical technology design, commercialization, industry consulting and M&A partnering experience. Licensed as an RN in Oregon and North Carolina. She has served as Industry Advisor to the Oregon Health & Science University Biomedical Innovation Program (BIP) and Clinical Translational Research Institute (OCTRI) since 2012.

Kurt Noltensmeyer, VP of Operations
Kurt Noltensmyer

Kurt Noltensmeyer brings over 20 years of experience in electrical engineering at industry-leading medical device companies. At Medtronic, he implemented a process that increased both manufacturability and profit margin. Kurt has extensive experience in managing engineering departments and cross-functional teams. He was appointed Engineering Leader for the CAPA Board from 2008 through 2015 and has received multiple certifications in management training programs. Kurt holds a Master’s of Science degree in Electrical Engineering from Southern Illinois University Edwardsville.

Stacy Sprouse, VP of Sales
Stacy Sprouse

Ms. Sprouse has a broad background in sales management, marketing, and product development. Most recently, she was the Vice President of Sales and Marketing for Syncroness, Inc., an engineering services company specializing in development of medical device and aerospace products. Prior to that, she held leadership positions at Medtronic in the Neuro, Spine, and ENT groups and at Cardiac Science Corporation and Criticare Systems Inc., leaders in diagnostic cardiology, defibrillation, and patient monitoring.

Scientific Advisory Board

Robert G. Hauser, MD, FACC, FHRS, Chair
Dr. Hauser, Chair of the Cardiac Insight Scientific Advisory Board, is former President of the Heart Rhythm Society, a senior consulting cardiologist at the Minneapolis Heart Institute®, and past president of the Cardiovascular Services Division at Abbott Northwestern Hospital in Minneapolis. Dr. Hauser’s major career research interest is the safety and efficacy of implantable pacemakers and defibrillators. He has published multiple papers regarding the reliability and performance of implantable cardiac rhythm management devices. Dr. Hauser is also actively engaged in innovations in arrhythmia detection, particularly atrial fibrillation, in at-risk populations.

Victor Froelicher, MD, FACC, FAHA, FACSM
A professor of medicine at Stanford University and cardiologist to Stanford University athletes, Dr. Froelicher is respected worldwide for his knowledge about cardiology, exercise, computerized electrocardiography and the cardiovascular system. Dr. Froelicher has been director of the ECG and Exercise Testing Laboratories at the Palo Alto Veterans Affairs Health Care System since 1992.Previously, he served 11 years in the U.S. Air Force and as Chief of Cardiology at the Long Beach Veterans Affairs Medical Center and principal investigator of the NIHLBI randomized trial of cardiac rehabilitation called PERFEXT.

John Camm is Professor of Clinical Cardiology at St. Georges, University of London, and Professor of Cardiology at London’s Imperial College. He is a Fellow of the Royal College of Physicians, and an experienced researcher and clinician focused on addressing specific issues associated with atrial fibrillation, other cardiac arrhythmias and sudden cardiac death. Professor Camm has led a top group of specialists, the European Network for Translational Research in Atrial Fibrillation (EUTRAF). He is currently President of the European Heart Rhythm Association and the Arrhythmia Alliance.

Albert L. Waldo, MD, FACC, FAHA, FACP, FHRS
Albert L. Waldo, MD is The Walter H. Pritchard Professor of Cardiology, Professor of Medicine, and Professor of Biomedical Engineering at Case Western Reserve University School of Medicine, Cleveland, Ohio. He is also Associate Chief of Cardiovascular Medicine for Academic Affairs at University Hospitals Cleveland Medical Center. He is a Fellow of the American College of Cardiology and served as President of the Ohio Chapter; former President of the North American Society of Pacing and Electrophysiology (NASPE), now called the Heart Rhythm Society (HRS); a Fellow and founding member of HRS; a Fellow of the American College of Physicians, American Heart Association and the American College of Chest Physicians. Dr. Waldo served as President of the Cardiac Electrophysiology Society and has held committee memberships with the National Institutes of Health.

Early testing can avert disaster, but false positives are stressful and costly. Now there’s a solution…from a company called Cardiac Insight.